BHVNBiohaven Ltd. is a clinical-stage biopharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, including migraine treatments and rare diseases. It's a high-risk, high-reward biotech play, with volatility tied to clinical trial results and pipeline advanc
